Medical

Weight-Loss Drug Price Wars Are Upending Big Pharma’s Business Model

Prices for popular GLP-1 weight-loss drugs are falling rapidly, pressuring pharmaceutical companies to overhaul pricing strategies and rethink long-term business…

2 weeks ago

Boston Scientific Stock Is on Pause. Its Earnings Could Get It Moving Higher Again

Boston Scientific Corp. (NYSE: BSX), a leading global medical device manufacturer, is facing an unusual period of stagnation. Known for…

7 months ago

Trump’s 200% Tariff Threat Leaves Pharma Firms Scrambling for Contingency Plans

Novartis AG NOVN --.--% Sanofi SA SAN --.--% Roche Holding AG ROG --.--% Eli Lilly and Co LLY --.--% Johnson…

7 months ago

Rite Aid’s second bankruptcy filing comes surprisingly soon, less than a year after the company’s previous emergence from Chapter 11

Rite Aid filed for bankruptcy protection Monday for the second time, less than a year after the embattled drugstore chain…

10 months ago

Johnson & Johnson Adjusts Its AI Strategy

Johnson & Johnson has shifted its generative AI strategy away from broad experimentation across the healthcare conglomerate to a more focused…

10 months ago

This website uses cookies.